Page last updated: 2024-11-05

tolbutamide and Achondroplasia

tolbutamide has been researched along with Achondroplasia in 2 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Achondroplasia: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GERSHBERG, H1
MARI, S1
HULSE, M1
STPAUL, H1
Blizzard, RM1
McKusick, VA1

Other Studies

2 other studies available for tolbutamide and Achondroplasia

ArticleYear
LONG-TERM TREATMENT OF HYPOPITUITARY AND OF ACHONDROPLASTIC DWARFISM WITH HUMAN GROWTH HORMONE.
    Metabolism: clinical and experimental, 1964, Volume: 13

    Topics: Achondroplasia; Adolescent; Child; Dwarfism; Dwarfism, Pituitary; Growth; Growth Hormone; Human Grow

1964
Letter: Tolbutamide and achondroplasia.
    JAMA, 1974, Jun-10, Volume: 228, Issue:11

    Topics: Achondroplasia; Age Factors; Child, Preschool; Humans; Hypoglycemia; Infant; Tolbutamide

1974